Overview
Qin Wang practices practicing medicine in Chengdu, China.
Their clinical expertise encompasses Hyperparathyroidism, COVID-19, Parathyroid Adenoma, and X-Linked Hypophosphatemia.
They are actively involved in clinical research, co-authoring 12 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Qin Wang
Is Qin Wang a top-rated expert for Hyperparathyroidism?
MediFind is an objective health platform that identifies experts based on real-world data. Qin Wang is classified as an Experienced expert for Hyperparathyroidism, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Qin Wang participate in research or clinical trials?
Yes. Qin Wang has published 12 articles and abstracts on conditions like Hyperparathyroidism. You can view a list of Qin Wang's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- COVID-19Wang isExperienced. Learn about COVID-19.
- HyperparathyroidismWang isExperienced. Learn about Hyperparathyroidism.
- Parathyroid AdenomaWang isExperienced. Learn about Parathyroid Adenoma.
- X-Linked HypophosphatemiaWang isExperienced. Learn about X-Linked Hypophosphatemia.